HHS

Accumulus Synergy Adds Two World-Class Executives to Its Leadership Team

Retrieved on: 
Thursday, March 7, 2024

BURLINGAME, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Accumulus Synergy, Inc. (“Accumulus”) today announced the appointment of Chanille Juneau, Chief Product Officer, and Dr. Kevin Charest, Chief Information Security Officer.

Key Points: 
  • BURLINGAME, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Accumulus Synergy, Inc. (“Accumulus”) today announced the appointment of Chanille Juneau, Chief Product Officer, and Dr. Kevin Charest, Chief Information Security Officer.
  • “I am thrilled to add Chanille and Kevin to our team,” said Francisco Nogueira, Accumulus CEO.
  • Dr. Kevin Charest joins Accumulus Synergy from HITRUST, where he jointly served as Chief Information Security Officer and Chief Technology Officer.
  • At Accumulus Synergy, Dr. Charest is responsible for all aspects of the information security program and enterprise technology initiatives.

AirBoss Reports 4th Quarter and Full Year 2023 Results

Retrieved on: 
Thursday, March 7, 2024

For the quarter and 2023, volume was down 17.5% with decreases across the majority of sectors given softness in many customer sectors.

Key Points: 
  • For the quarter and 2023, volume was down 17.5% with decreases across the majority of sectors given softness in many customer sectors.
  • Tolling volume was down 63.0% in the quarter and 59.6% in 2023, from the comparable periods in 2022.
  • Non-tolling volume was down 9.9% for the quarter and by 7.4% in 2023, compared to the same periods in 2022.
  • AirBoss now reports results under two segments: (1) AirBoss Rubber Solutions (“ARS”), and (2) AirBoss Manufactured Products (“AMP”).

US Department of Health and Human Services Selects Inmar Intelligence for a 5-year Contract to Deliver Pharmaceutical Supply Chain Solutions

Retrieved on: 
Tuesday, February 20, 2024

Winston-Salem, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Inmar Intelligence , a leading provider of data-driven healthcare technology solutions, today announced it has secured a contract with the US Department of Health and Human Services (HHS) to provide pharmaceutical supply chain solutions across the country.

Key Points: 
  • Winston-Salem, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Inmar Intelligence , a leading provider of data-driven healthcare technology solutions, today announced it has secured a contract with the US Department of Health and Human Services (HHS) to provide pharmaceutical supply chain solutions across the country.
  • With pharmaceutical supply chain management needs at an all-time high, this contract represents a timely opportunity for Inmar to deploy its tech-enabled pharmaceutical services nationwide.
  • Leveraging decades of expertise providing tech-forward solutions, Inmar will support HHS in their mission to protect public health and provide essential human services.
  • With health emergencies on the rise, Inmar reaffirms its dedication to helping safeguard public health services now and into the future.

Empatica Reveals Next Generation FDA-Cleared Epilepsy Watch and Launches AI Seizure Forecasting Study

Retrieved on: 
Wednesday, February 28, 2024

Empatica, a leader in remote health monitoring powered by AI, is proud to announce the official launch of EpiMonitor , the latest advancement in wearable epilepsy monitoring.

Key Points: 
  • Empatica, a leader in remote health monitoring powered by AI, is proud to announce the official launch of EpiMonitor , the latest advancement in wearable epilepsy monitoring.
  • In December 2023, Empatica also announced plans to conduct a groundbreaking study to develop a seizure forecasting algorithm, based on the world’s largest real-world data set in epilepsy patients.
  • “Our FORESIGHT clinical study is an incredibly exciting opportunity to advance personalized seizure forecasting,” said Dr. Marisa Cruz, Empatica’s Chief Medical Officer.
  • In 2018, Empatica’s Embrace wearable received FDA clearance for seizure monitoring, making it the world's first epilepsy watch to be cleared by the FDA.

PointClickCare Sets Industry Standard in Long-Term and Post-Acute Care (LTPAC) with New ONC Health IT Certification

Retrieved on: 
Monday, February 26, 2024

This certification reinforces the company’s commitment to patient safety, improving health outcomes and reducing the cost of care – the core tenets of Value-Based Care (VBC).

Key Points: 
  • This certification reinforces the company’s commitment to patient safety, improving health outcomes and reducing the cost of care – the core tenets of Value-Based Care (VBC).
  • The ONC Health IT Certification Program is a pivotal initiative that validates health IT products' compliance with federal standards and criteria set by the Department of Health and Human Services (HHS).
  • “PointClickCare's ONC CEHRT designation signifies a commitment to LTPAC providers that we’re invested in their success, inclusive of any value-based reimbursement models they’re participating in,” said B.J.
  • To learn more about this industry recognition, and how it serves as a mark of quality and reliability in the health IT market, visit our website here .

Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Thursday, February 22, 2024

Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2023.

Key Points: 
  • Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2023.
  • Complete 24-week treatment data for 30 participants per regimen is expected in the fourth quarter of 2024.
  • The MARCH Part B trial is ongoing with 48-week end of treatment data expected in the fourth quarter of 2024.
  • Revenues: Total revenues for the quarter ended December 31, 2023 were $16.8 million compared to $49.4 million for the same period in 2022.

Second-time Awardees CyncHealth, PointClickCare, Innsena Granted $80,000 Racial Equity in Postpartum Care Federal Funding

Retrieved on: 
Tuesday, February 20, 2024

CyncHealth , the designated health information exchange (HIE) for Nebraska and Iowa; PointClickCare , a leading healthcare technology platform; and Innsena , a health tech consultancy focused on improving care outcomes for underserved communities, won the second phase of a U.S. Department of Health and Human Services’ Racial Equity in Postpartum Care Challenge —including federal funding of $80,000, for their innovative postpartum care program in Nebraska.

Key Points: 
  • CyncHealth , the designated health information exchange (HIE) for Nebraska and Iowa; PointClickCare , a leading healthcare technology platform; and Innsena , a health tech consultancy focused on improving care outcomes for underserved communities, won the second phase of a U.S. Department of Health and Human Services’ Racial Equity in Postpartum Care Challenge —including federal funding of $80,000, for their innovative postpartum care program in Nebraska.
  • “More than 80% of postpartum deaths are preventable, meaning lack of attentive and coordinated care is central to this devastating statistic,” says Jaime Bland, CEO of CyncHealth.
  • This award recognizes the proven success of this model,” says Britteny Matero, vice president of Market Access for Innsena.
  • “We’ve worked hard to develop and track actionable implementation steps for other states to take so that nationwide mortality and morbidity for women postpartum can be significantly reduced.”
    To learn more about the HHS Racial Equity in Postpartum Care Challenge, visit: https://www.hhs.gov/about/news/2024/02/14/hhs-announces-final-phase-winn...

Netsmart Supports Whole-Person Care Provisions in 42 CFR Part 2 Final Rule

Retrieved on: 
Tuesday, February 20, 2024

Strengthens penalties by applying the same requirements of the HIPAA Breach Notification Rule to breaches of records under Part 2.

Key Points: 
  • Strengthens penalties by applying the same requirements of the HIPAA Breach Notification Rule to breaches of records under Part 2.
  • As a founding member of The Partnership to Amend 42 CFR Part 2 , Scalia stated the long-awaited Final Rule is another step forward for coordinated, whole-person care for individuals nationwide.
  • These major changes to 42 CFR Part 2 will take effect on February 16, 2026.
  • To learn more about these regulation changes, read the 42 CFR Part 2 Final Rule Fact Sheet and register for the upcoming Netsmart webinar on Thursday, March 28 at 1 p.m.

New CDC Respiratory Guidance Ignores Kidney Patient Concerns

Retrieved on: 
Thursday, March 7, 2024

WASHINGTON, March 7, 2024 /PRNewswire/ -- Today, the American Association of Kidney Patients (AAKP), the largest and oldest independent kidney patient organization in the nation, issued an Official Statement (appears below) in response to the Center for Disease Prevention and Control's (CDC) new Respiratory Virus Guidance, publicly announced on March 1, 2024. The CDC announcement occurred on the first day of National Kidney Month. March traditionally unites kidney stakeholders and people of goodwill in efforts to raise awareness of kidney diseases, address ongoing unmet patient needs, and advocate for removal of federal regulatory and payment barriers that impede access to, and development of, new kidney diagnostics, drugs, and devices.

Key Points: 
  • Mortality rates among kidney patients occurred at historic levels at the start of the COVID pandemic, devastated the kidney patient community and families, and this community's ongoing risks remain a strategic concern among patient advocates and allied kidney professionals.
  • AAKP also raised kidney patient health and safety concerns to CDC officials in stakeholder briefings prior to the March 1, 2024, CDC Respiratory Virus Guidance announcement.
  • The American Association of Kidney Patients (AAKP), the nation's largest and oldest independent kidney patient organization in the nation, is deeply concerned about the Center for Disease Prevention Control's (CDC) Respiratory Virus Guidelines, including for COVID, announced on March 1, 2024.
  • https://www.cdc.gov/mmwr/volumes/73/wr/mm7308a5.htm
    Since 1969, The American Association of Kidney Patients has been a patient-led organization driving policy discussions on kidney patient care choice and medical innovation.

Baby2Baby Launches Partnership with Huggies-maker Kimberly-Clark to Provide Millions of Diapers and Wipes to Mothers In Need and Triple Their Maternal Health & Newborn Supply Kit Initiative

Retrieved on: 
Wednesday, March 6, 2024

LOS ANGELES and DALLAS, March 6, 2024 /PRNewswire/ -- Baby2Baby, a national nonprofit organization, and Huggies diapers are joining forces to provide crucial support to new mothers and babies with a program that will launch timed to Mother's Day 2024. In an effort to address rising diaper need in America and combat the tragically rising maternal mortality rate, Huggies, through the Kimberly-Clark Foundation, has committed to tripling the reach and impact of Baby2Baby's initiative with The Department of Health and Human Services (HHS). Through a multi-million-dollar grant including funds and an in-kind product donation of its diapers, wipes and postpartum pads the program will support maternal and infant health, particularly among vulnerable communities. 

Key Points: 
  • These critical items also provide mental health support by alleviating the stress of meeting their baby's most basic needs.
  • "Not being able to afford the items their babies need takes a profound toll on a mother's mental health.
  • The partnership between Baby2Baby and Huggies underscores a shared commitment to reducing this shocking statistic while supporting maternal and infant health in communities in need.
  • While Baby2Baby has distributed 170 million diapers in the past 12 years, that is still just a fraction of the need.